China's API extortion from Indian pharma breaking down
The API coming from China started getting dumped in India at very low prices.
The API coming from China started getting dumped in India at very low prices.
One of the key agenda before the committee will be to design a price moderation framework for emerging and precision therapies to facilitate their timely reach to the needy patients.
The government issued a directive instructing pharmaceutical industry associations to ensure "strict compliance" with the UCPMP 2024.
Established with a clear vision, Akums remains unwavering in its commitment to excel in the pharmaceutical industry.
The company reported a consolidated net profit of ₹5 crore in the July to September quarter of FY24. The company had reported a loss of ₹37 crore in the same period last year.
The stellar run continues post-Covid as promoters reap benefits of growth in India and new launches in key markets.
Nine established pharma companies will be selected on the basis of their willingness to carry out research in six priority areas with academic collaboration in government research institutions.
In a letter to Mansukh Mandaviya, AIMED says the final draft of the Bill does not propose an independent regulatory regime for medical devices
The revenue from operations of the Mumbai-based company stood at ₹11,940.8 crore, up 10.9% as against 10,761.7 crore in the Q1 of FY23.
Glenmark Pharmaceutical said that the settlement will make clear that the company denies allegations by the Plaintiff groups.